Kumasi Field Report - PowerPoint PPT Presentation

1 / 15
About This Presentation
Title:

Kumasi Field Report

Description:

Dr. Alfredo MacArthur, NACP Mozambique. Dr. Bernard Dornoo, WHO-NACP Ghana ... Prohibitive lab costs for biochemistry tests. Pharmacy Capacity ... – PowerPoint PPT presentation

Number of Views:39
Avg rating:3.0/5.0
Slides: 16
Provided by: wb957
Category:

less

Transcript and Presenter's Notes

Title: Kumasi Field Report


1
Kumasi Field Report
  • January 15 16, 2007

2
Team Composition
  • Mr. Israel Sembajwe, ECA
  • Dr. Alfredo MacArthur, NACP Mozambique
  • Dr. Bernard Dornoo, WHO-NACP Ghana
  • Dr. Richard Amenyah, FHI Ghana
  • Cassandra de Souza, World Bank

3
Sites Visited
  • Komfo Anokye Teaching Hospital, Kumasi
  • St. Michaels Hospital, Pramso
  • Obuasi Government Hospital
  • AngloGold Ashanti Hospital, Obuasi

4
Health Social Demographics
  • Ashanti Region, 21 districts
  • Population is 4.2 million
  • HIV prevalence 3.0 vs. 2.7 national
  • 7 ART sites, 34 PMTCT and VCT sites
  • Over 5,000 enrolled patients
  • Almost 2,200 patients on ART

5
ART Situation Overview
  • ART initiated in region in February 2004
  • 6 additional sites added during 2006
  • 98 of ART patients are at K.A.T.H
  • Most patients are diagnostic referrals,
    presenting late
  • Team approach to care (5 trained staff per site)
  • Patient inflow follows national protocol
    guidelines
  • Walk-in/referral, initial nurse assessment,
    doctor initiated treatment, 3 adherence
    counseling sessions

6
TAP Implementation
  • Implementation begun in 2006
  • Each site has less than 50 ART patients
  • Public private partnership operational eg.
    Obuasi Govt. and Anglogold, St. Michaels, CRS and
    Kumasi South
  • Regular monitoring and supervision provided
  • Some HBC and community outreach evident eg.
    Anglogold and community engagement Pramso social
    mobilization

7
Laboratory Capacity
  • CD4 machines not available in all sites samples
    taken to other sites, strengthen links
  • Highly controlled utilization of machines
  • Chemical analyzer not available in most sites
  • At least 2 motivated and well-trained lab techs
    per site (heavily involved in care)
  • HIV lab reagent stockouts in past 6 months
  • Prohibitive lab costs for biochemistry tests

8
Pharmacy Capacity
  • Pharmacists integrated in overall care provision
    often serve as adherence counselors
  • Regular drug monitoring and reporting
  • No stockouts in last 6 months for 1st line
    regimen
  • Shortage of 2nd line drugs at K.A.T.H.

9
Integration/Linkages
  • PMTCT and TB are integrated
  • STIs referral linkage is weak
  • VCT weak generally, mostly diagnostic CT which is
    well integrated

10
Supporting Activities
  • Training for 5 staff per site prior to ART
    initiation
  • Regular technical support provided (for TAP
    sites)
  • Regular programmatic supervision by regional AIDS
    coordinator (quarterly)
  • Strengthen the quality assurance system for
    scaling up to new sites to monitor adherence to
    standards (with checklist)

11
Monitoring Evaluation
  • Sites provide monthly programmatic reports to
    Regional AIDS Coordinator (K.A.T.H. sends direct
    to NACP)
  • TAP sites provide monthly reports to implementing
    partner (FHI,NCHS unclear)
  • Data collected but not locally analyzed and
    utilized for programmatic decisions
  • Utilization of national reporting format for
    figures, age and gender defined

12
Good Practices
  • Public Private Partnership
  • Good collaboration between Anglogold and Obuasi
    hospitals
  • Where available, engagement of other partners
    (CRS and St. Michaels)
  • Team approach and skills mix
  • Self-motivated and committed lab technicians and
    pharmacists
  • Free services to employees and dependants at
    Anglogold
  • Staff mentoring by IPs

13
Constraints/Challenges
  • Cost, cost, cost, cost!
  • Chemical analyzers needed
  • Space limitations in some sites
  • Late entry into care
  • Adherence monitors sometimes challenging
  • Human resource limitations
  • Low utilization of ART services
  • Low community mobilization and interventions
  • Stigma

14
Recommendations
  • Regular and well-planned technical support and
    supervision should be strengthened
  • Strengthen quality assurance system for new sites
    to monitor adherence to standards (with
    checklist)
  • VCT promotion highlighted as a primary prevention
    mechanism and for early ART initiation
  • Significant improvement in community outreach
    activities social marketing of VCT and ART
    marketing
  • Need aggressive identification of paediatric
    cases
  • Provision of basic lab equipment
  • Strategic HR capacity building for all sites
    need-based
  • Localized data analysis and utilization for
    ownership
  • Review of 50,000 cedis package charge and policy
    guidance on use of these funds
  • Inclusion of ARVs in health insurance scheme

15
  • Obrigado
  • Webale Nnyo
  • Me da se
  • Zikomo
Write a Comment
User Comments (0)
About PowerShow.com